Prognostic of older age for patients with invasive-muscle-bladder cancer and treated by radical cystectomy

被引:3
|
作者
Dehayni, Y. [1 ]
Tetou, M. [1 ]
Khdach, Y. [1 ]
Janane, A. [1 ]
Alami, M. [1 ]
Ameur, A. [1 ]
机构
[1] Hop Mil Instruct Mohamed V, Serv Urol, Rabat, Morocco
来源
PROGRES EN UROLOGIE | 2018年 / 28卷 / 03期
关键词
Bladder; Tumor; Age; Prognosis; Survival; CHEMOTHERAPY; SURVIVAL; OUTCOMES; PREDICT;
D O I
10.1016/j.purol.2017.12.005
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction. - Bladder tumor is a disease of older persons, but can also occur in young adults, because certainly an influence of environmental factors and a change of lifestyle. The aim of our retrospective analysis is to assess and evaluate the extent of the prognostic impact of age on the carcinological prognosis of invasive-muscle-bladder cancer treated by total cystotomy. Methods. - To evaluate the association of patient age with pathological characteristics and recurrence-free and disease survival, we retrospectively reviewed 345 patients with invasive bladder cancer between January 2000 and January 2015. Results. - We divided our patients into two groups: patients under 65 years of age = 150 cases (group 1), patients aged 65 years and over = 195 cases (group 2). The 3-year survival rates for patients according to the age groups were 88% and 64% respectively, end the recurrence free survival 66% and 28%. When age was analysed as a categorical variable, was associated with hydronephrosis (P = 0.001), advanced pathological stage (P = 0.034), high grade (P = 0.026), nodal involvement (P = 0.011) and lymphovascular invasion (P = 0.008). The multivariate Cox model analysis showed that hydronephrosis and pathological stage was prognostic factors of survival (P = 0.012 and P = 0.035, respectively). Higher age is significantly associated with the risk of pathologically advanced disease and poorer global survival. Conclusion. - This work allowed us to assert that advanced chronological age is significantly associated with an advanced pathological stage of the disease (volume, pT, grade, lymph nodes) and a low overall survival rate. This could be useful for selecting subjects who would require adjuvant therapy, as well as for planning early complementary therapies. (c) 2017 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:166 / 172
页数:7
相关论文
共 50 条
  • [31] Radical cystectomy as a muscle-invasive bladder cancer treatment in elderly patients
    March, Villalba J. A.
    Martinez, Jabaloyas J. M.
    Pastor, Hernandez F.
    Gunther, Stefan F. J.
    Rodriguez, Navarro R.
    Chuan, Nunez P.
    ACTAS UROLOGICAS ESPANOLAS, 2008, 32 (07): : 696 - 704
  • [32] Incidental prostate cancer in patients undergoing radical cystectomy for muscle invasive bladder cancer
    Lindenmeir, T.
    Liehr, U. B.
    Rau, O.
    Reiher, F.
    Allhoff, E. P.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 220 - 220
  • [33] THE CURABILITY OF INVASIVE BLADDER-CANCER TREATED BY RADICAL CYSTECTOMY
    BREDAEL, JJ
    CROKER, BP
    GLENN, JF
    EUROPEAN UROLOGY, 1980, 6 (04) : 206 - 210
  • [34] Prognostic Significance of Hydronephrosis in Bladder Cancer Treated by Radical Cystectomy
    Resorlu, Berkan
    Baltaci, Sumer
    Resorlu, Mustafa
    Ergun, Gul
    Abdulmajeed, Mohammed
    Haliloglu, Ahmet Hakan
    Gogus, Cagatay
    Beduk, Yasar
    UROLOGIA INTERNATIONALIS, 2009, 83 (03) : 285 - 288
  • [35] The prognostic value of hydronephrosis in bladder cancer treated by radical cystectomy
    Lin, Huan-yi
    Wang, Sheng-zheng
    Chen, Jun-xing
    Chen, Ling-wu
    Xiao, Jun
    UROLOGIA JOURNAL, 2011, 78 (01) : 17 - 21
  • [36] Delays in radical cystectomy for muscle-invasive bladder cancer
    Chu, Alice T.
    Holt, Sarah K.
    Wright, Jonathan L.
    Ramos, Jorge D.
    Grivas, Petros
    Yu, Evan Y.
    Gore, John L.
    CANCER, 2019, 125 (12) : 2011 - 2017
  • [37] Muscle invasive bladder cancer after radical cystectomy. Prognostic factors of adjuvant chemotherapy
    Thissen, A. K.
    Pfister, D.
    Heidenreich, A.
    UROLOGE, 2013, 52 (09): : 1233 - 1241
  • [38] Comparison of Outcomes in Patients With Muscle-Invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder-Preserving Chemoradiation
    Zhong, J.
    Switchenko, J.
    Jegadeesh, N.
    Gillespie, T. W.
    Master, V. A.
    Nieh, P.
    Alemozaffar, M.
    Kucuk, O.
    Carthon, B.
    Filson, C. P.
    Jani, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S93 - S94
  • [39] Use of Radical Cystectomy for Patients With Invasive Bladder Cancer
    Gore, John L.
    Litwin, Mark S.
    Lai, Julie
    Yano, Elizabeth M.
    Madison, Rodger
    Setodji, Claude
    Adams, John L.
    Saigal, Christopher S.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (11): : 802 - 811
  • [40] Effects of perioperative chemotherapy on prognosis in muscle invasive bladder cancer treated with radical cystectomy.
    Hatakeyama, Shingo
    Taoka, Rikiya
    Miki, Jun
    Saito, Ryoichi
    Fukuokaya, Wataru
    Matsui, Yasuyuki
    Kawahara, Takashi
    Matsuda, Ayumu
    Kawai, Taketo
    Kato, Minoru
    Sazuka, Tomokazu
    Sano, Takeshi
    Urabe, Fumihiko
    Kashima, Soki
    Naito, Hirohito
    Murakami, Youji
    Nishiyama, Naotaka
    Nishiyama, Hiroyuki
    Kitamura, Hiroshi
    Ohyama, Chikara
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 592 - 592